Evidence map›Paper›PMID 22695809›Full record

ReviewWiener medizinische Wochenschrift (1946)2012

Tick-borne encephalitis: Clinical findings and prognosis in adults.

Reinhard Kaiser

Abstract readComparative StudyReview
PubMed Publisher
In one paragraph

Review in Wiener medizinische Wochenschrift (1946), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Outcome and Sequelae of Infectious Encephalitis.Journal of clinical neurology (Seoul, Korea) · 2024
    Review
  12. Review
  13. Tick-Borne Encephalitis (TBE): From Tick to Pathology.Journal of clinical medicine · 2023
    Review
  14. Review
  15. Article
  16. Article
  17. Deaths from Tick-Borne Encephalitis, Sweden.Emerging infectious diseases · 2022
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Reinhard KaiserNeurological Clinic, Clinical Center of Pforzheim, Kanzlerstraße 2-6, 75175, Pforzheim, Germany. rkaiser@klinikum-pforzheim.de
Siloah St. Trudpert Klinikum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In middle and eastern European countries, tick-borne encephalitis (TBE) is one of the most important human infections of the central nervous system. TBE virus (TBEV) is mainly transmitted by tick bites and in very rare cases by unpasteurized milk. The incubation period is on an average 7-10 days. A biphasic course of illness with a prodromal period occurs in about two third of patients. In European countries, TBE presents as meningitis in about 50 % of patients, as meningoencephalitis in 40 %, and as meningoencephalomyelitis in 10 %. The severity of TBE increases with age, in children and adolescents, meningitis is the predominant form of the disease. Long-term prognosis is unfavorable in about 40-50 % of patients who suffer from sequelae for months to years, mainly in terms of pareses, ataxia, and other gait disturbances. No specific treatment for TBE is known so far, but TBE can be successfully prevented by active immunization.

Indexed as

AdolescentAdultAgedAge FactorsAnimalsAntibody SpecificityCentral Nervous System DiseasesChildCross-Cultural ComparisonCross-Sectional StudiesDiagnosis, DifferentialEncephalitis, Tick-BorneEncephalitis Viruses, Tick-BorneEuropeFollow-Up StudiesHumansImmunoglobulin GImmunoglobulin M

Identifiers

PMID22695809
OpenAlexW166663645

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.